Global Blood Therapeutics IncMost Recent.Company & Industry OverviewsGlobal Blood Therapeutics Trades Higher, Sickle Cell Therapy DataYesterday, Global Blood Therapeutics (GBT), a clinical-stage biopharmaceutical company, announced positive top-line data for its Phase 3 HOPE study of its Voxelotor therapy for sickle cell disease.
.Company & Industry OverviewsGlobal Blood Therapeutics Trades Higher, Sickle Cell Therapy DataYesterday, Global Blood Therapeutics (GBT), a clinical-stage biopharmaceutical company, announced positive top-line data for its Phase 3 HOPE study of its Voxelotor therapy for sickle cell disease.
